14
Participants
Start Date
September 20, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
NTI164
Full-Spectrum Medicinal Cannabis Plant Extract containing 0.08% THC, administered orally starting with a dose of 5 mg/kg, titrated up to 20 mg/kg based on tolerance, followed by a maintenance phase at the maximum tolerated dose, and concluding with a gradual dose reduction.
The Childrens Hospital at Westmead, Sydney
Collaborators (1)
Neurotech International Limited
INDUSTRY
Fenix Innovation Group
INDUSTRY